Bernard Lerer: Pre-clinical, translational and clinical research focused on the use of psychedelic drugs and their derivatives to treat psychiatric disorders
Psychedelics · 2024
DOI: 10.61373/pp024k.0004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychedelics, 2024. Verfasst von Bernard Lerer. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Professor Bernard Lerer is in the Faculty of Medicine, Hebrew University, Jerusalem, Israel, where he is Director the Center for Psychedelic Research ( https://cfpr.brainlabs.org.il/ ) at Hadassah Medical Center, in Jerusalem. The Center has a growing staff that includes senior scientists, post-docs, Ph.D. and graduate students, technicians, and psychiatrists undergoing research training. Their research is preclinical, translational, and clinical and focuses on the use of psychedelic drugs and their derivatives to treat psychiatric disorders. Previously, he was Head of the Biological Psychiatry Unit at Hadassah Medical Center for 30 years, with research and clinical responsibilities. A conversation with Professor Lerer covered topics on his life and career.
Zitieren
APA
Lerer, B. (2024). Bernard Lerer: Pre-clinical, translational and clinical research focused on the use of psychedelic drugs and their derivatives to treat psychiatric disorders. Psychedelics. https://doi.org/10.61373/pp024k.0004
Vancouver
Lerer B. Bernard Lerer: Pre-clinical, translational and clinical research focused on the use of psychedelic drugs and their derivatives to treat psychiatric disorders. Psychedelics. 2024. doi:10.61373/pp024k.0004
BibTeX
@article{Lerer2024,
author = {Lerer, Bernard},
title = {Bernard Lerer: Pre-clinical, translational and clinical research focused on the use of psychedelic drugs and their derivatives to treat psychiatric disorders},
journal = {Psychedelics},
year = {2024},
doi = {10.61373/pp024k.0004}
}
EUVIMED